Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-105730
Filing Date
2024-12-04
Accepted
2024-12-04 21:13:32
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4258
  Complete submission text file 0001213900-24-105730.txt   5835
Mailing Address 499 ILLINOIS STREET, SUITE 200 SAN FRANCISCO CA 94158
Business Address
Ehrlich Christopher B (Reporting) CIK: 0001293973 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40877 | Film No.: 241527605

Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001870404 (see all company filings)

EIN.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)